Cargando…

Multiparametric [(11)C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer

BACKGROUND: The aim of this study was to evaluate whether MP [(11)C]Acetate PET-MRI enables an accurate differentiation of benign and malignant prostate tumors as well as local and distant staging. MATERIALS AND METHODS: Fifty-six consecutive patients fulfilling the following criteria were included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polanec, Stephan H., Andrzejewski, Piotr, Baltzer, Pascal A. T., Helbich, Thomas H., Stiglbauer, Alexander, Georg, Dietmar, Karanikas, Georgios, Susani, Martin, Wadsak, Wolfgang, Margreiter, Markus, Mitterhauser, Markus, Brader, Peter, Pinker, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515396/ https://www.ncbi.nlm.nih.gov/pubmed/28719629 http://dx.doi.org/10.1371/journal.pone.0180790

Ejemplares similares

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET
por: Georg, Petra, et al.
Publicado: (2017)

Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
por: Andrzejewski, Piotr, et al.
Publicado: (2019)

3D T2-weighted imaging to shorten multiparametric prostate MRI protocols
por: Polanec, Stephan H., et al.
Publicado: (2017)

Diffusion‐Weighted MRI of Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic b‐Values
por: Bickel, Hubert, et al.
Publicado: (2019)

Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI
por: Sodano, Claudia, et al.
Publicado: (2020)

[(11)C]acetate PET as a tool for diagnosis of liver steatosis
por: Nejabat, Marzieh, et al.
Publicado: (2018)

A Simultaneous Multiparametric (18)F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2022)

AI-enhanced simultaneous multiparametric (18)F-FDG PET/MRI for accurate breast cancer diagnosis
por: Romeo, V., et al.
Publicado: (2021)

Breast Lesion Classification with Multiparametric Breast MRI Using Radiomics and Machine Learning: A Comparison with Radiologists’ Performance
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2022)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2021)

Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI
por: Wengert, G. J., et al.
Publicado: (2019)

Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer
por: Daniel, M., et al.
Publicado: (2018)

MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience
por: Spick, Claudio, et al.
Publicado: (2016)

Syntheses of Precursors and Reference Compounds of the Melanin-Concentrating Hormone Receptor 1 (MCHR1) Tracers [(11)C]SNAP-7941 and [(18)F]FE@SNAP for Positron Emission Tomography
por: Schirmer, Eva, et al.
Publicado: (2013)

Density and tailored breast cancer screening: practice and prediction – an overview
por: Wengert, Georg J, et al.
Publicado: (2018)

Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1)
por: Philippe, Cécile, et al.
Publicado: (2013)

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging
por: Giraudo, Chiara, et al.
Publicado: (2016)

Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features
por: Vogl, Wolf-Dieter, et al.
Publicado: (2019)

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
por: Minarikova, Lenka, et al.
Publicado: (2016)

Imaging Biomarkers or Biomarker Imaging?
por: Mitterhauser, Markus, et al.
Publicado: (2014)

**-Postprandial pancreatic [(11)C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release
por: Steiner, Emanuel, et al.
Publicado: (2016)

Reliable set-up for in-loop (11)C-carboxylations using Grignard reactions for the preparation of [carbonyl-(11)C]WAY-100635 and [(11)C]-(+)-PHNO()
por: Rami-Mark, Christina, et al.
Publicado: (2013)

Virtual Touch IQ elastography reduces unnecessary breast biopsies by applying quantitative “rule-in” and “rule-out” threshold values
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

A Simple Ultrasound Based Classification Algorithm Allows Differentiation of Benign from Malignant Breast Lesions by Using Only Quantitative Parameters
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment
por: Wengert, Georg J., et al.
Publicado: (2019)

[(18)F]FE@SNAP—A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): Microfluidic and vessel-based approaches
por: Philippe, Cécile, et al.
Publicado: (2012)

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
por: Spies, Marie, et al.
Publicado: (2017)

Multiparametric MRI model with dynamic contrast‐enhanced and diffusion‐weighted imaging enables breast cancer diagnosis with high accuracy
por: Zhang, Michelle, et al.
Publicado: (2018)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)

A multiparametric [(18)F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis
por: Leithner, Doris, et al.
Publicado: (2019)

Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo
por: James, Gregory M, et al.
Publicado: (2019)

The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
por: Li, Shuren, et al.
Publicado: (2017)

Radiosynthesis of [(11)C]SNAP-7941—the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1)
por: Philippe, C., et al.
Publicado: (2012)

Simultaneous 18F-FDG PET/MRI Radiomics and Machine Learning Analysis of the Primary Breast Tumor for the Preoperative Prediction of Axillary Lymph Node Status in Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2023)

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
por: Bauer, Martin, et al.
Publicado: (2017)

An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
por: Pötsch, Nina, et al.
Publicado: (2021)

Feasibility and Optimal Time Point of [(68)Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery
por: Huebner, Nicolai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6crnm0bnvd7cd53dhm3hgmpf0